![\"Breast](\"https:\/\/WowRxPharmacy.com\/wp-content\/uploads\/2023\/04\/Breast-Pain-1-1024x536.webp\")
The symptoms of triple-negative breast cancer are similar to those experienced by all breast cancer patients. Breast cancer is typically categorized into stages ranging from zero to four. Higher numbers indicate more advanced and invasive cancer. It’s important to note that the stage of TNBC can influence treatment options and prognosis. <\/p>\n\n\n Treatment for triple-negative breast cancer typically involves a combination of surgery, chemotherapy, and radiation therapy. Platinum-based chemotherapy is often used to treat advanced-stage triple-negative breast cancer. Triple-negative breast cancer is a subtype of breast cancer that is negative for Estrogen receptor (ER), Progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is important to note that having one or more risk factors does not necessarily mean a person will develop TNBC. Localized triple-negative breast cancer that has not spread beyond the breast has a five-year relative survival rate<\/a> of 91%. These statistics are collected and recorded in the SEER database by the NCI, but as research and cancer treatment continues to evolve, the patient outlook may improve.<\/p>\n\n\n Triple-negative breast cancer (TNBC) is a highly aggressive form of cancer that lacks the three receptors commonly used to guide treatment for other types of breast cancer<\/a>. Triple-negative breast cancer is a subtype of breast cancer that lacks three specific receptors often found in other types of breast cancer, making it more aggressive and challenging to treat.<\/p>\n\n<\/div>\n<\/div>\n The exact causes of triple-negative breast cancer are not fully understood. However, researchers have identified some risk factors, such as family history of breast cancer, BRCA1 gene mutations, obesity, and certain reproductive factors. Additionally, triple-negative breast cancer may be more common in younger women.<\/p>\n\n<\/div>\n<\/div>\n Treatment for triple-negative breast cancer typically involves surgery, chemotherapy, and radiation therapy. It can be more aggressive and harder to treat than other types of breast cancer. Women with triple-negative breast cancer can be cured with appropriate treatment. However, the prognosis varies depending on the cancer stage and other factors.\u00a0<\/p>\n\n<\/div>\n<\/div>\n The survival rate for triple-negative breast cancer varies depending on the stage at diagnosis. For localized cancer, the five-year relative survival rate is 91 percent.\u00a0<\/p>\n\n<\/div>\n<\/div>\n It is a more aggressive form of breast cancer; advancements in research and treatment options like hormone therapy and targeted therapy are continually being made to improve outcomes and survival rates for women with this subtype of breast cancer.\u00a0<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n Triple Negative Breast Cancer (TNBC) is an aggressive subtype of breast cancer. TNBC accounts for about 10-20% of all breast cancers and tends to occur commonly in younger women and those with a family history of the disease. Unlike other types of invasive breast cancer, TNBC is typically more aggressive, has limited treatment options, and […]<\/p>","protected":false},"author":10,"featured_media":21338,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[528],"tags":[1466,1467,1469,1471],"class_list":["post-21337","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-womens-health","tag-breast-cancer","tag-womens-health","tag-womens-health-symptoms","tag-womens-health-treatment"],"_links":{"self":[{"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/posts\/21337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/comments?post=21337"}],"version-history":[{"count":1,"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/posts\/21337\/revisions"}],"predecessor-version":[{"id":26418,"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/posts\/21337\/revisions\/26418"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/media\/21338"}],"wp:attachment":[{"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/media?parent=21337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/categories?post=21337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wowrxpharmacy.com\/fr\/wp-json\/wp\/v2\/tags?post=21337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
A lump is a standard indicator, which may be painless, hard, and irregular.
But can also be painful, soft, and round. Other indications<\/a> may include the following:<\/p>\n\n\n\n\n
Stages of Triple negative breast cancer<\/h2>\n\n\n
The stages of TNBC are as follows<\/a>:<\/p>\n\n\n\n\n
Triple-negative breast cancer treatment<\/h2>\n\n\n
![\"Radioth\u00e9rapie\"](\"https:\/\/WowRxPharmacy.com\/wp-content\/uploads\/2023\/04\/Radiation-therapy-2-1024x536.webp\")
Hormone therapy and targeted therapy, which are efficace<\/a> for other types of breast cancer, are ineffective for triple-negative breast cancer due to the absence of hormone receptors and HER2 protein.
Surgery to remove the tumor is often recommended for<\/a> early-stage triple-negative breast cancer.
In some cases, chemotherapy may be given before surgery to shrink the tumor and make it easier to remove.
After surgery, chemotherapy may be given<\/a> to reduce the risk of cancer recurrence.
Radiation therapy may also be recommended<\/a> after surgery to destroy any remaining cancer cells and reduce the risk of recurrence.<\/p>\n\n\n
In some cases<\/a>, PARP inhibitors, antibody-drug conjugates, and immunotherapy with chemotherapy may also be used.
PARP inhibitors are a cancer drug class that targets specific molecules in cancer cells.
They are currently used as a treatment option for certain types of ovarian cancer, and ongoing clinical trials are exploring their potential use for treating other types of cancer.
It’s essential to work with a healthcare team to develop an individualized treatment plan based on the specific characteristics of cancer and individual factors such as age and overall health.<\/p>\n\n\nRisk factors for Triple-negative breast cancer<\/h2>\n\n\n
The risk factors for TNBC are not fully understood<\/a>, but some factors that may increase the risk of developing TNBC include:<\/p>\n\n\n\n\n
Regular breast cancer screening and early detection<\/a> can help improve outcomes for people with TNBC.<\/p>\n\n\nTNBC survival rate & prognosis<\/h2>\n\n\n
This means the patient is 91% as likely as someone without cancer to survive during that time. <\/p>\n\n\nConclusion<\/h2>\n\n\n
TNBC tends to occur in younger women.
Due to its aggressive nature, TNBC has a poorer prognosis than other types of breast cancer, and it often requires a different approach to treatments like hormones and targeted therapy.
However, ongoing research continues to explore new treatments and improve outcomes for women with TNBC.<\/p>\n\n\nQuestions fr\u00e9quemment pos\u00e9es<\/h2>\n\n
What is triple-negative breast cancer?<\/h3>\n
What causes triple-negative breast cancer?<\/h3>\n
Can you be cured from triple-negative breast cancer?<\/h3>\n
What is the survival rate of triple-negative breast cancer?<\/h3>\n
Is there hope for triple-negative breast cancer?<\/h3>\n
\nWowRx<\/a> Nous utilisons uniquement des sources de haute qualit\u00e9 pour la r\u00e9daction de nos articles. Veuillez lire notre politique d'information sur le contenu<\/a> pour en savoir plus sur la mani\u00e8re dont nous gardons notre contenu fiable et digne de confiance.<\/div><\/div>\n\n